| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $95,181,079 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AG075393 | ANG1-7 as an intervention for Alzheimer's Disease. | 000 | 2 | NIH | 1/26/2024 | $202,129 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AG079794 | Characterizing Retinal Tissue Oxygenation, Structure, and Function in Alzheimer's Disease | 000 | 2 | NIH | 1/10/2024 | $167,063 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K01HL163249 | Silent Zones of Lung Disease in COPD | 000 | 2 | NIH | 12/14/2023 | $168,237 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30DK135345 | Coordination of T cell-derived signals in intestinal epithelial barrier defense | 000 | 2 | NIH | 2/23/2024 | $41,349 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | H1748968 | Healthy Tomorrows Partnership for Children Program | 00 | 2 | HRSA | 3/11/2024 | $21,860 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DA054714 | Role of Gadd45b in Cocaine-driven Epigenetic and Behavioral Dynamics | 000 | 3 | NIH | 3/15/2024 | $575,726 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK134402 | Regulation of Macrophage Phenotype by Ferritin Heavy Chain in CKD | 000 | 2 | NIH | 1/9/2024 | $380,518 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01ES035072 | Environmental Cadmium, persistent inflammation and airways disease | 001 | 2 | NIH | 2/26/2024 | $442,572 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AA029072 | Circadian and mitochondrial dysfunction in alcohol-related liver disease | 000 | 2 | NIH | 3/26/2024 | $412,065 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01MD019235 | Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases | 000 | 2 | NIH | 3/21/2024 | $447,135 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01MD019235 | Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groupswith Rheumatic Diseases | 000 | 2 | NIH | 3/21/2024 | $112,500 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG082089 | The role of IncRNA Neat1 in Alzheimer's disease and related memory deficits | 000 | 2 | NIH | 3/18/2024 | $591,400 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01EY035313 | Neural Control of Choroidal Function | 000 | 2 | NIH | 4/22/2024 | $486,122 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01GM141546 | Role Of Retinoid Oxidoreductase Complex In Controlling The Embryonic Development | 000 | 2 | NIH | 3/18/2024 | $280,665 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AG082327 | Lifespan extension, Somatotropic signaling and Tauopathy | 000 | 2 | NIH | 3/4/2024 | $167,063 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG081228 | Drugs repositioning to target TREM2 in Alzheimer disease | 000 | 2 | NIH | 2/13/2024 | $529,032 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG082352 | Peripheral Biomarkers for Early Diagnosis of Mixed Pathologies in AD/ADRD | 000 | 2 | NIH | 3/5/2024 | $669,491 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG078708 | IMPORTANCE OF PERIODONTITIS IN THE INNATE IMMUNE REGULATION OF ALZHEIMER'S DISEASE | 000 | 2 | NIH | 2/28/2024 | $334,125 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K23DK135844 | Social and Dietary Determinants of Kidney Stone Risk | 000 | 2 | NIH | 3/5/2024 | $181,079 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21HD109358 | Improving Cardiorespiratory Fitness and Cardiometabolic Health among Children with Physical Disabilities through Movement-to-Music Telehealth with Arm-based Sprint-Intensity Interval Training | 000 | 2 | NIH | 4/16/2024 | $167,063 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01AG081433 | Role of GlcSph in cognitive deficits in Lewy body dementias | 000 | 2 | NIH | 4/19/2024 | $593,379 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA271303 | Adapting Enhanced Recovery Programs (ERPs) through Health Literacy to Eliminate Surgical Disparities | 000 | 2 | NIH | 4/4/2024 | $555,620 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA270750 | Employing Humanized Microbiome Mice to Understand Immune Activation and Translational Therapeutic Potential in Glioblastoma | 000 | 2 | NIH | 4/8/2024 | $312,852 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K23HL173704 | A Double Blinded Randomized Feasibility Trial on the Use of Plant Based Omega-3-Fatty Acids (Flaxseed) to Improve Inflammation Driven Pain Outcomes in Children with Sickle Cell Anemia | 000 | 1 | NIH | 3/14/2024 | $171,180 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31GM154463 | Structurally Defining rBH3 Interactions | 000 | 1 | NIH | 3/28/2024 | $41,349 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31GM154463 | Structurally Defining rBH3 Interactions | 001 | 1 | NIH | 3/28/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K23HD108345 | Use of early time-restricted eating to promote weight loss and improve cardiometabolic health in postpartum women | 000 | 1 | NIH | 2/29/2024 | $123,838 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01MH135451 | Multidimensional aging trajectories in mid to late-life psychosis (MAP) | 000 | 1 | NIH | 12/15/2023 | $976,906 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21CA277267 | Targeting actionable liabilities in Merlin-deficient breast cancer | 000 | 1 | NIH | 12/27/2023 | $173,559 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21CA288243 | CRISPR and Humanized mice-based Discovery of a Novel Drug target for HCC Therapy | 000 | 1 | NIH | 2/6/2024 | $208,271 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK139059 | Optimizing an extended care intervention to promote weight loss maintenance | 000 | 1 | NIH | 4/23/2024 | $645,957 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA279021 | Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project) | 000 | 1 | NIH | 3/14/2024 | $561,565 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K01AG086063 | A Pilot Trial of High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Older Adults with HIV. | 000 | 1 | NIH | 12/15/2023 | $125,982 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30DA057821 | Role of Reelin protein in the cellular and behavioral response to drugs of abuse | 001 | 1 | NIH | 3/13/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30DA057821 | Role of Reelin protein in the cellular and behavioral response to drugs of abuse | 000 | 1 | NIH | 3/13/2024 | $41,349 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21DA059844 | Microbial Biofilms as Regulators of Amphetamine Use Disorders | 000 | 1 | NIH | 3/8/2024 | $185,625 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31GM150237 | Identifying Gestational-induced Changes in Islet Macrophages as a Potential Target for Beta-cell Expansion | 001 | 1 | NIH | 1/22/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31GM150237 | Identifying Gestational-induced Changes in Islet Macrophages as a Potential Target for Beta-cell Expansion | 000 | 1 | NIH | 1/22/2024 | $40,647 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31AI183737 | Elucidating the Proteolytic Determinants of Flavivirus Infection | 000 | 1 | NIH | 3/20/2024 | $43,012 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | UG3NS130202 | Stimulus-evoked directional field potentials to guide subthalamic and pallidal DBS for PD | 000 | 1 | NIH | 12/18/2023 | $1,232,410 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01DK134310 | Differentiating slow from rapidly progressive ADPKD by cell-specific mitochondrial and transcriptional profiles | 000 | 1 | NIH | 3/29/2024 | $491,400 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AG084218 | Comprehensive Assessment of Delirium Risk due to Medications | 000 | 1 | NIH | 11/17/2023 | $214,990 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01HL168031 | Role of DHRS9 in oxylipin metabolism | 000 | 1 | NIH | 4/19/2024 | $639,013 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | K01HL166370 | An investigation of the long-term impact of in-utero exposure to mild chronic hypertension and antihypertensive therapy on childhood subclinical cardiovascular risk factors | 000 | 1 | NIH | 4/18/2024 | $166,746 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F30AG085889 | Interactions between progranulin insufficiency and TDP-43 | 000 | 1 | NIH | 12/7/2023 | $41,349 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | F31DK137440 | Elucidating the Role of the Rnf20 Histone Modifier in Pancreatic Beta Cell Function and Senescence | 000 | 1 | NIH | 3/18/2024 | $43,563 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R21AI175868 | Divergence of V-region sequences from the human proteome as a factor in autoimmune diseases and the immunogenicity of therapeutic antibodies. | 000 | 1 | NIH | 11/22/2023 | $167,063 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA290435 | DCE-MRI guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer | 000 | 1 | NIH | 3/18/2024 | $669,747 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA AT BIRMINGHAM | 701 S 20TH STREET | BIRMINGHAM | AL | 35294-0001 | JEFFERSON | USA | R01CA282701 | Role of CXCR3-CXCL10 signaling in T-ALL CNS disease | 000 | 1 | NIH | 3/25/2024 | $449,218 |
|